AtriCure Inc.
Organization details
- Legal name
- AtriCure Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Mason
- Headquarters state / province
- Ohio
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ATRC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001323885
- EIN
- 34-1940305
- Wikidata ID
- Q30256881
Board of directors
-
B. Kristine Johnson · DirectorSince 2023
-
Deborah H. Telman · DirectorSince 2023
-
Karen Prange · DirectorSince 2023
-
Maggie Yuen · DirectorSince 2023
-
Mark A. Collar · DirectorSince 2023
-
Michael H. Carrel · Director · President, CEO, & DirectorSince 2023
-
Regina E. Groves · DirectorSince 2023
-
Robert S. White · DirectorSince 2023
-
Shlomo Nachman · DirectorSince 2024
-
Sven Wehrwein · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 18, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
97.2%
-
97.4%
-
98.4%
-
98.5%
-
98.6%
-
99.0%
-
99.4%
-
99.4%
-
99.4%
Board connections
5 of this board's directors also sit on 7 other boards. 5 are in the same sector.
-
ClearPoint Neuro Inc. Same sectorvia B. Kristine Johnson
-
Embecta Corp. Same sectorvia Karen Prange
-
Fulgent Genetics Inc. Same sectorvia Regina E. Groves
-
Inspire Medical Systems Inc. Same sectorvia Michael H. Carrel
-
Outset Medical Inc. Same sectorvia Karen Prange
- via Sven Wehrwein
- via Sven Wehrwein
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $5,059,678
- 19 sales by 9 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 6, 2026 | B. Kristine Johnson Director | Open-market sale | −2,452 | $58.48 | $143,393 |
| Nov 4, 2026 | Privitera Salvatore Officer (Chief Technical Officer) | Open-market sale | −8,404 | $65.00 | $546,260 |
| Sep 23, 2026 | Privitera Salvatore Officer (Chief Technical Officer) | Open-market sale | −4,519 | $60.00 | $271,140 |
| Sep 11, 2026 | Regina E. Groves Director | Open-market sale | −5,313 | $54.22 | $288,071 |
| Sep 8, 2026 | Privitera Salvatore Officer (Chief Technical Officer) | Open-market sale | −3,657 | $55.00 | $201,135 |
| Sep 2, 2026 | Privitera Salvatore Officer (Chief Technical Officer) | Open-market sale | −7,763 | $52.50 | $407,558 |
| Aug 24, 2026 | Dahlquist Karl S. Officer (Chief Legal Officer) | Open-market sale | −9,370 | $48.89 | $458,099 |
| Aug 5, 2026 | Karen Prange Director | Open-market sale | −3,564 | $38.80 | $138,283 |
| Aug 5, 2026 | Maggie Yuen Director | Open-market sale | −3,500 | $38.42 | $134,470 |
| Jul 30, 2026 | Michael H. Carrel Director, Officer (President, CEO, & Director) | Gift | −700 | — | — |
| Jul 30, 2026 | Michael H. Carrel Director, Officer (President, CEO, & Director) | Gift | −4,000 | — | — |
| Jul 29, 2026 | Noznesky Justin J Officer (Chief Mktg & Strategy Officer) | Open-market sale | −6,182 | $38.80 | $239,862 |
| Jul 28, 2026 | Sven Wehrwein Director | Option exercise | +25,000 | $19.95 | $498,750 |
| Jul 28, 2026 | Doraiswamy Vinayak Officer (Chief Scientific Officer) | Open-market sale | −6,000 | $38.88 | $233,280 |
| Jul 28, 2026 | Sven Wehrwein Director | Open-market sale | −25,000 | $37.84 | $946,000 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about AtriCure Inc.
Who is the CEO of AtriCure Inc.?
Michael H. Carrel is AtriCure Inc.'s President, CEO, & Director.
How many directors are on AtriCure Inc.'s board?
AtriCure Inc.'s board has 10 directors: B. Kristine Johnson, Deborah H. Telman, Karen Prange, Maggie Yuen, Mark A. Collar, Michael H. Carrel, Regina E. Groves, Robert S. White, Shlomo Nachman and Sven Wehrwein.
Are AtriCure Inc. insiders buying or selling shares?
Over the last 12 months, AtriCure Inc. insiders made no open-market purchases and sold $5.1 million of shares in 19 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="atricure-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.